Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN1382030

serine/threonine Kinase 17a (STK17A) (N-Term) Peptide

Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms DRAK1, RDRAK1, im:6905684, LOC100226911, STK17A
Protein Region
»Alternatives Human
Blocking Peptide (BP)
Pubmed 3 references available
Catalog no. ABIN1382030
Quantity 0.05 mg
77.00 $   Plus shipping costs $45.00
Shipping to
Availability Please inquire for availability
Characteristics 15 amino amino terminus of human DRAK1.
Alternative Name DRAK1
Research Area Signaling, Apoptosis/Necrosis
Application Notes DRAK1 peptide is used for blocking the activity of DRAK1.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Storage -20 °C
Expiry Date 12 months
Background publications Wesche, Korherr, Kracht et al.: "The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)." in: The Journal of biological chemistry, Vol. 272, Issue 12, pp. 7727-31, 1997 (PubMed).

Hofmeister, Wiegmann, Korherr et al.: "Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein." in: The Journal of biological chemistry, Vol. 272, Issue 44, pp. 27730-6, 1997 (PubMed).

Sanjo, Kawai, Akira: "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, 1998 (PubMed).

Alternatives for antigen "serine/threonine Kinase 17a (STK17A)", type "Peptides"
Reactivities (1)